|
T29168 |
XR-5000
|
NSC-601316,CRC8805,SN-22995,DACA,CRC-8805 |
|
|
XR-5000 is a DNA topoisomerase I and II inhibitor. |
|
T1239 |
Indacaterol maleate
|
QAB149 |
Adrenergic Receptor
|
|
Indacaterol maleate (QAB149) is an ultra-long-acting β-adrenoceptor agonist. |
|
T2320 |
Indacaterol
|
|
Adrenergic Receptor
|
|
Indacaterol (Onbrez; Arcapta) is a β2-Adrenergic Agonist. The mechanism of action of indacaterol is as an Adrenergic beta2-Agonist. |
|
T1120 |
Dacarbazine
|
Imidazole Carboxamide,DTIC-Dome |
Apoptosis
,
Nucleoside Antimetabolite/Analog
,
DNA/RNA Synthesis
|
|
Dacarbazine (DTIC-Dome) is an antineoplastic agent. It has significant activity against melanomas. |
|
T36898 |
Sandacanol
|
Sandranol,2-Ethyl-4-(2,2,3-trimethylcyclopent-3-en-yl)-but-2-en-1-ol |
Apoptosis
|
|
Sandacanol（Sandranol） is a selective olfactory receptor (OR10H1) agonist. Sandacanol can induce cell cycle arrest and partial apoptosis in bladder cancer cells, and can reduce cell migration rate and proliferation rate. |
|
T1120L |
Dacarbazine hydrochloride
|
Dacarbazine HCl |
|
|
Dacarbazine ( imidazole carboxamide) is a chemotherapy drug used to treat melanoma and Hodgkin's lymphoma. |
|
T71658 |
Indacaterol xinafoate
|
|
|
|
Indacaterol xinafoate is an ultra-long-acting beta-adrenoceptor agonist. |
|
T71659 |
Indacaterol acetate
|
|
|
|
Indacaterol acetate is an ultra-long-acting beta-adrenoceptor agonist. |
|
T1120L2 |
Dacarbazine citrate
|
DTIC citrate |
|
|
Dacarbazine citrate is an alkylating agent used to treat cancers of the lymphatic system and malignant melanoma (a type of skin cancer) in patients with certain conditions: islet cell carcinoma (part of the pancreas) Sof... |
|
T71660 |
Indacaterol fumarate
|
|
|
|
Indacaterol fumarate is an ultra-long-acting beta-adrenoceptor agonist. |
|
T36695 |
TAS-103
|
|
|
|
TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.
TAS-103 is a dual inhibitor of DNA topoisomerase I/II. TAS-103 (0.1-10 μM) is active on CCRF-CEM cells, with an IC50 value of 5 nM. TAS-103... |
